FDA Inspection 1067958 — Medtech Southeast, Inc.
The FDA completed an inspection of Medtech Southeast, Inc. on Jul 11, 2018 in Tifton, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 11, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Tifton, GA (United States)